https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

PathoCare Holdings, Inc. Accepts Third-Party Tender Offer Valuing the Company at $500 Million and Launches New Equity Round to Support Product Development

HOUSTON–(BUSINESS WIRE)–PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the Lab-on-a-Chip non-invasive Point of Care diagnostics)—has developed a set of tests backed by a revolutionary Raman spectroscopy-based testing platform that is underpinned by 17 patents and adaptive AI. Today, the company announced that it has accepted a third-party tender offer involving the secondary purchase of shares from an early investor. While specific tra

administrator

Related Articles